VISTA PHARMACEUTICALS LTD. - 524711 - Board Meeting Outcome for Outcome Of Board Meeting- Regulation 30
Outcome of Board Meeting- Regulation 3006-09-2023
06-09-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 06.09.2023
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2023 ,inter alia, to consider and approve 1. To revise notice, consider and convene the 32 annual General Meeting of the company and to fix the date, time, and venue for the same. 2. To consider and approve the draft Notice for the 32nd Annual General Meeting of the Members of the Company. 3. To consider and approve the proposal for raising funds by way of issue of Preferential issue of equity shares01-09-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Revised Financial Results For The Quarter Ended 30Th June 2023- Regulations 33(3)(A) Ref:Ack 6013958,
The Board of Directors of the Company at its Meeting held on Saturday 12th August 2023 at 4.00 P.M at the Corporate office of the Company has considered and approved the unaudited financials results for the Quarter ended 30th June 202301-09-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment
Kindly take note of the allotment of 5,52,821 equity shares on conversion of 5,52,821 warrants to others on a preferential basis.26-08-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Newspaper Advertisement For The Quarter Ended 30.06.2023
Newspaper advertisement of unaudited financial statements for the quarter ended 30.06.202322-08-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Financial Results For The Quarter Ended 30Th June 2023
Financial Results for the Quarter ended 30th June 202312-08-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Board Meeting Outcome for Outcome Of Board Meeting - Regulation 30
It is hereby informed that the Board of Directors of the Company at its Meeting held on Saturday, 12th August 2023.at 04:00 PM and ended at 4:55 P.M at the corporate office of the Company considered and approved the following as attached12-08-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Board Meeting Intimation for The Meeting Of The Board Of Directors Of The M/S. Vista Pharmaceuticals Limited Will Be Held On Saturday, 12.08.2023 At 04:00 P.M At Plot No 104 Ravindra Co-Operative Housing Society Guttala Begumpet Shaikpet TG 500033
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve 1. To consider, approve and take on record the un-audited Financial Results of the company for the quarter ended 30th June, 2023. 2. To consider and take note of Limited Review Report for the quarter ended 30th June, 2023. 3. To consider and approve the Board of Directors' Report on the company's activities for the financial year ended 31st March, 2023. 4. To take note of the Secretarial Audit Report for the financial year ended 31st March, 2023. 5. To take note of the Certificate of Managing Director & Chief Financial Officer of the Company for the financial year ended 31st March, 2023. 6. To Consider the appointment of Scrutinizer for E-voting at Annual General meeting 7. To consider and convene the 29th Annual General Meeting of the company and to fix the date, time and venue for the same. 8. To consider and approve the draft Notice for the 29th Annual General Meeting of the Members of the Company. 9. Any other item with the permission of the Chair05-08-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment
Kindly take note of the allotment of 23,32,625 equity shares on conversion of 23,32,625 warrants to others on a preferential Basis18-07-2023
VISTA PHARMACEUTICALS LTD. - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations 201814-07-2023